In an ApoE knockout mice fed a high-lipid diet, a well-known atherosclerosisprone murine model, it has been demonstrated the efficacy of LAV-BPIFB4 in contrasting endothelial dysfunction, plaque progression, inflammatory cytokine release, macrophage shift, and T cell activation. Here, BPIFB4 is linked to endothelial dysfunction.